(Q72505358)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8201582%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

review article

1 reference

title

Oral bile acids in cystic fibrosis-associated liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8201582%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

Colombo C

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8201582%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Crosignani A

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8201582%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Apostolo MG

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8201582%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Marzano MT

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8201582%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Bettinardi N

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8201582%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Giunta A

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8201582%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8201582%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

number of pages

5

1 reference

Journal of the Royal Society of Medicine

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8201582%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

87 Suppl 21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8201582%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

20-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8201582%20AND%20SRC:MED&resulttype=core&format=json

Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts

27 October 2019

cites work

1 reference

12 December 2020

Taurine decreases fecal fatty acid and sterol excretion in cystic fibrosis. A randomized double-blind trial

1 reference

12 December 2020

Cystic fibrosis: ultrasonographic findings in the pancreas and hepatobiliary system correlated with clinical data and pathology

1 reference

12 December 2020

Ursodeoxycholic acid for primary biliary cirrhosis

1 reference

12 December 2020

Liver disease and common-bile-duct stenosis in cystic fibrosis

1 reference

12 December 2020

Ursodeoxycholic acid in biliary atresia

1 reference

12 December 2020

Excessive Fecal Taurine Loss Predisposes to Taurine Deficiency in Cystic Fibrosis

1 reference

12 December 2020

Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid

1 reference

12 December 2020

Epidemiology of ulcerative colitis in western Norway

1 reference

12 December 2020

Meconium ileus and its equivalent as a risk factor for the development of cirrhosis: an autopsy study in cystic fibrosis

1 reference

12 December 2020

Liver disease and bile duct abnormalities in adults with cystic fibrosis

1 reference

12 December 2020

Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis

1 reference

12 December 2020

Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration

1 reference

12 December 2020

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis

1 reference

12 December 2020

Prevalence of liver disease in cystic fibrosis

1 reference

12 December 2020

Ursodeoxycholic acid in chronic liver disease

1 reference

12 December 2020

Cystic fibrosis: beyond the gene to therapy

1 reference

12 December 2020

Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy

1 reference

12 December 2020

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease

1 reference

12 December 2020

Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis

1 reference

12 December 2020

Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.

1 reference

12 December 2020

Prognosis in cystic fibrosis

1 reference

12 December 2020

The changing epidemiology of cystic fibrosis

1 reference

12 December 2020

Regulation of membrane chloride currents in rat bile duct epithelial cells

1 reference

12 December 2020

Effect of taurine supplements on fat absorption in cystic fibrosis.

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8201582%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

PubMed publication ID

8201582

1 reference